These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6388467)

  • 1. [Treatment of systemic scleroderma].
    Priollet P; Baudot N; Fiessinger JN; Vayssairat M; Housset E
    Ann Dermatol Venereol; 1984; 111(6-7):595-607. PubMed ID: 6388467
    [No Abstract]   [Full Text] [Related]  

  • 2. Scleroderma: therapeutic options.
    Connolly SM
    Cutis; 1984 Sep; 34(3):274-6. PubMed ID: 6386354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation factor XIII in scleroderma.
    Jullien D; Souillet AL; Faure M; Claudy A
    Eur J Dermatol; 1998 Jun; 8(4):231-4. PubMed ID: 9649677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Scleroderma in the child. Treatment with colchicine].
    Harpey JP; Renault F; Roy C; Lafourcade J
    Nouv Presse Med; 1980 Oct; 9(38):2844. PubMed ID: 7443410
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of progressive systemic sclerosis using factor XIII.
    Guillevin L; Chouvet B; Mery C; De Gery A; Thivolet J; Godeau P; Delbarre F
    Pharmatherapeutica; 1985; 4(2):76-80. PubMed ID: 3903781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bronchiolo-alveolar carcinoma complicating systemic scleroderma under long-term treatment with factor XIII].
    Grivaux M; Pieron R
    Rev Pneumol Clin; 1987; 43(2):102-3. PubMed ID: 3039643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognosis and treatment of scleroderma].
    Crickx B; Belaich S
    Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis.
    Pearson ME; Stechschulte DJ
    J Kans Med Soc; 1984 Jan; 85(1):13-7. PubMed ID: 6368712
    [No Abstract]   [Full Text] [Related]  

  • 9. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic action of coagulation factor XIII in scleroderma. 20 cases].
    Thivolet J; Perrot H; Meunier F; Bouchet B
    Nouv Presse Med; 1975 Nov; 4(39):2779-82. PubMed ID: 1105424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.
    Steen VD; Medsger TA
    Arthritis Rheum; 1998 Sep; 41(9):1613-9. PubMed ID: 9751093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term treatment of systemic scleroderma with coagulation factor XIII. Developmental monitoring, especially of respiratory function].
    Euller-Ziegler L; Corolleur YR; Marcou J; Commandre F; Grisot C; Ziegler G
    Rev Rhum Mal Osteoartic; 1984 Oct; 51(9):503-5. PubMed ID: 6505601
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor XIII treatment for scleroderma.
    Delbarre F; Godeau P; Thivolet J
    Lancet; 1981 Jul; 2(8239):204. PubMed ID: 6114269
    [No Abstract]   [Full Text] [Related]  

  • 14. Favorable effects of plasma factor XIII on lower esophageal sphincter pressure of progressive systemic sclerosis.
    Maekawa Y; Nogita T; Yamada M
    Arch Dermatol; 1987 Nov; 123(11):1440-1. PubMed ID: 3674907
    [No Abstract]   [Full Text] [Related]  

  • 15. [A prospective study of plasma exchange in the treatment of diffuse scleroderma].
    Ding C; Zhang X
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):616-9. PubMed ID: 8697930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonoperative treatment of digital ischemia in systemic sclerosis.
    Wall LB; Stern PJ
    J Hand Surg Am; 2012 Sep; 37(9):1907-9. PubMed ID: 22483176
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of systemic sclerosis.
    Medsger TA
    Ann Rheum Dis; 1991 Nov; 50 Suppl 4(Suppl 4):877-86. PubMed ID: 1750801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the treatment of scleroderma].
    Marquet R; Vilardell M
    Med Clin (Barc); 1984 Jun; 83(2):74-7. PubMed ID: 6147448
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current treatment of systemic sclerosis. Part II. Vascular and antifibrotic treatment].
    Sicińska J; Rudnicka L
    Pol Merkur Lekarski; 2008 Aug; 25(146):196-200. PubMed ID: 18942347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis.
    Thompson AE; Shea B; Welch V; Fenlon D; Pope JE
    Arthritis Rheum; 2001 Aug; 44(8):1841-7. PubMed ID: 11508437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.